Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06426342
Other study ID # Mindguide_Employee
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date July 30, 2024
Est. completion date February 28, 2025

Study information

Verified date May 2024
Source Ewha Womans University
Contact Suk-Sun Kim, PhD
Phone +82-2-3277-2885
Email suksunkim@ewha.ac.kr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this feasibility study is to develop a new metaverse-based blended online intervention using an online program and coaching via metaverse to prevent depression among Generation MZ Employees in South Korea. In addition, this study primarily explores reach and acceptability and secondarily evaluates the preliminary effectiveness of this preventive intervention on Korea's Gen MZ Employees.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 140
Est. completion date February 28, 2025
Est. primary completion date December 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 42 Years
Eligibility Inclusion Criteria: - Generation MZ Employees of South Korea who are aged between 20 and 42; Millennials were born between 1981 to 1996, and Generation Zs were born between 1997 to 2004 Exclusion Criteria: - 1) being unemployed or having less than 1 year job experience, - 2) having mental disorders such as schizophrenia or substance abuse (as this is a preventive intervention) and currently attending other mental health therapy to avoid mixing effects.

Study Design


Intervention

Behavioral:
metaverse-based blended online intervention
A new metaverse-based blended online intervention was developed using an online program and coaching via metaverse to prevent depression among Generation MZ Employees in South Korea.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Ewha Womans University

Outcome

Type Measure Description Time frame Safety issue
Primary Recruitment Recruitment will be assessed by the number of potentially eligible participants enrolled. Initial (before intervention)
Primary The retention rate The retention rate will be calculated as the percentage of completion rates for the entire intervention and questionnaires until the completion of a 5 weeks after intervention. Initial(before intervention), at 5 weeks after intervention.
Primary Acceptability Acceptability refers to how participants perceive and feel about the intervention and its components (Ayala & Elder, 2011; Sekhon et al., 2017). A 13- item questionnaire was developed based on the Client Satisfaction Questionnaire (CSQ) (Larsen et al., 1979; Sveen et al., 2021) to measure acceptability with three subcategories: helpfulness (three items), suitability (seven items), and satisfaction (three items). Participants responded on a 5- point Likert scale ranging from 1 (not at all) to 5 (very). at 5 weeks after intervention.
Secondary Depression scale The Center for Epidemiological Studies Depression Scale (CES-D; Radloff, 1977; Chon et al., 2001) with 20- item will be used to measure depressive symptoms using a 4- point Likert scale. The total score ranges from 0 to 60, with higher scores indicating higher levels of depressive symptoms. Initial(before intervention), at 5 weeks after intervention.
Secondary Positive and Negative Affect Schedule Positive and Negative Affect Schedule (PANAS; Watson et al., 1988; Park & Lee, 2016) will used to measure positive and negative affect using a 5- point Likert scale. The total score ranges from 10 to 50, with higher scores indicating a greater perception of positive affect or negative affect. Initial(before intervention), at 5 weeks after intervention.
Secondary Satisfaction with Life Scale the Satisfaction with Life Scale (SWLS; Diener et al., 1985; Lim et al., 2010) with 5- items will be used to assess life satisfaction using a 7- point Likert scale.
The total score ranges from 5 to 35, with higher scores indicating greater life satisfaction.
Initial(before intervention), at 5 weeks after intervention.
Secondary Burnout assessment tool Burnout assessment tool (BAT; Schaufeli et al., 2020; Cho, 2020) with 23 items will be used to measure burnout including four core burnout symptoms: Exhaustion, Mental Distance, Emotional Impairment, and Cognitive Impairment. Exhaustion is the loss of physical and mental energy. Mental distance refers to psychological distancing from work or people at work. Emotional impairment is emotional reactions, such as frustration and irritability, brought on by burnout; and Cognitive impairmentthe is memory problems, attention and concentration deficits and poor cognitive performance. Initial(before intervention), at 5 weeks after intervention.
Secondary Sleep Quality scale Pittsburgh Sleep Quality Index (PSQI; Buysse et al., 1989; Sohn, 2012) with 19 items will be used to evaluate overall sleep quality. 19 self-reported items includes seven subcategories: subjective sleep quality, sleep latency, sleep duration, habitual sleep effi ciency, sleep disturbances, use of sleeping medication, and daytime dysfunction Initial(before intervention), at 5 weeks after intervention.
See also
  Status Clinical Trial Phase
Recruiting NCT06009523 - Effects of Transcranial Direct Current Stimulation (tDCS) in the Management of Suicidal Ideation N/A
Completed NCT02566980 - Biological Triggers of Depression in Pregnancy
Completed NCT04266288 - Effectiveness of Ketamine for Depression and Suicidal Ideation in the Emergency Department Phase 4
Recruiting NCT05437588 - Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents N/A
Recruiting NCT04760652 - Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention N/A
Active, not recruiting NCT05930912 - Psychiatric Orders in Psychoanalytic Treatment of ASD
Completed NCT03601117 - Accelerated Intermittent Theta Burst Stimulation for Depressive Symptoms N/A
Recruiting NCT04572321 - Youth Depression and Suicide Research Network